GXD-Bio v Myriad Genetics (CFI, 14 February 2025)
| Date | 14 February 2025 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Preliminary objection |
| Registry reference | App_51844/2024 · ORD_68782/2024 |
| Parties | GXD-Bio Corporation v. Myriad Genetics S.r.l., Myriad GmbH, Myriad Genetics S.A.S., Myriad Genetics B.V., Myriad Genetics, Inc., Myriad Servic… |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 14 February 2025 (ORD_68782/2024, UPC_CFI_437/2024), Ulrike Voß, judge rapporteur in the Munich Local Division, rejected the preliminary objection raised by eight Myriad group companies sued by GXD-Bio Corporation for infringement of EP 3 346 403. The defendants challenged the UPC’s competence over acts preceding GXD-Bio’s registration as proprietor, the related claims having been assigned by the former proprietors. The judge treated this as a question of standing, belonging to the merits, and granted leave to appeal.
Question
Does a challenge to the claimant’s right to sue for acts preceding its entry in the register, based on Arts 47 and 68 UPCA, fall within the preliminary objection to jurisdiction under Rule 19.1?
Decision
The grounds for a preliminary objection listed in Rule 19.1 are exhaustive (paragraph 13, citing Aylo v Dish). The objections concerned standing and substantive entitlement, not jurisdiction under Art. 32 UPCA, which says nothing about who may bring an action (paragraphs 14 and 15). Arts 47 and 68 are not implicitly part of Art. 32, as the structure of the UPCA confirms (paragraph 16). These issues belong to the main proceedings (paragraph 17). Subject-matter jurisdiction follows from Arts 32(1)(a), 2(g) and 3(c) UPCA, the patent not having expired by 1 June 2023 (paragraph 18). The auxiliary request to decide the objection in the main proceedings failed for the same reasons (paragraph 19). Leave to appeal was granted, since the question of law concerns many cases (paragraph 21).
Key points for practice
- A challenge to standing for the period before the assignee’s registration is argued on the merits rather than by way of preliminary objection.
- Leave to appeal under Rule 220.2 may be granted where the jurisdictional question is relevant to many cases.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 2(g), 3(c), 32(1)(a), 47 and 68(1)
- Rules of Procedure
- Rules 19.1, 20.1, 21.1 and 220.2, recital 8
- Case law cited
- Aylo v Dish, Court of Appeal, 3 September 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Local and central divisions (UPC).
Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction, Valeo v. Bosch and the Redistribution of Cases Within the UPC (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantGXD-Bio Corporation3 decisions in the corpusFollow this party
- defendantMyriad Genetics S.r.l.2 decisions in the corpusFollow this party
- defendantMyriad GmbHFollow this party
- defendantMyriad Genetics S.A.SFollow this party
- defendantMyriad Genetics B.V.2 decisions in the corpusFollow this party
- defendantMyriad Genetics, Inc.2 decisions in the corpusFollow this party
- defendantMyriad ServicFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Preliminary objection
- Outcome (Dhenne Avocats summary)
- La juge rapporteure rejette l'exception préliminaire des sociétés Myriad, la contestation du droit d'agir pour les actes antérieurs à l'inscription de GXD-Bio relevant de la qualité pour agir et du fond, et autorise l'appel.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 346 403mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- AYLO Premium v DISH Technologies (CoA, 3 September 2024) cited in this record
- Sun Patent Trust v Roku (CFI, 18 March 2025) cites this decision
- GXD-Bio v Myriad International (CFI, UPC_CFI_437/2024, 19 December 2025) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 346 403 | Mentioned in the analysis (role not qualified) Also mentioned in 2 other decision(s): GXD-Bio v Myriad International (CFI, UPC_CFI_437/2024, 19 December 202 · GXD-Bio v Myriad International (CFI, 26 November 2024) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.